GeneCast Company

GeneCast provides cancer screening, monitoring, precision care and accompanying diagnosis through source technology that amplifies only mutated genes.

Headquarters: South Korea
Last Funding Date: 43188
Funding Status: Early Stage Venture
Investors Number: 8
Founded Date: 42675
Last Funding Type: Series A
Total Funding: $93.5M
Industry: Health Care
Estimated Revenue: $1M to $10M
Technology: preventive